Abstract
Hypertension is considered as one of the major cardiovascular risk factors for the development of atherosclerosis, a chronic inflammatory disease of the arterial vasculature. Chronic activation of the renin angiotensin system (RAS) and enhanced oxidative stress are characteristic features of both, hypertension and atherosclerosis. In fact, Angiotensin II, the effector peptide of the RAS is a central mediator of vasoconstrictor and pro-inflammatory reactions in the cardiovascular system. Many of its effects are attributed to the formation of reactive oxygen species (ROS). Thus, angiotensin II via ROS may be a central link between hypertension and atherogenesis. In this review, we will summarize the current evidence proposing angiotensin II as a critical contributor to atherosclerotic plaque vulnerability via inflammation and hemodynamic alterations.
Keywords: Angiotensin II, reactive oxygen species, hypertension, atherosclerotic plaque stability
Related Journals
Related eBooks
Related Articles
-
COX-2 Inhibitors and Cardiovascular Events: Deja Vu Du Jour
Vascular Disease Prevention Interactions Between Advanced Glycation End-Products (AGE) and their Receptors in the Development and Progression of Diabetic Nephropathy – are these Receptors Valid Therapeutic Targets
Current Drug Targets Bariatric Surgery - Effects on Obesity and Related co-Morbidities
Current Diabetes Reviews The Renin-Angiotensin Systems: Evolving Pharmacological Perspectives for Cerebroprotection
Current Pharmaceutical Design Mas Receptor Agonists as Novel Antihypertensive Agents
Current Hypertension Reviews Cardiovascular Effects of Phosphodiesterase 5 Inhibitors
Current Pharmaceutical Design Independent Relationship of Osteocalcin Circulating Levels with Obesity, Type 2 Diabetes, Hypertension, and HDL Cholesterol
Endocrine, Metabolic & Immune Disorders - Drug Targets Glucocorticoids in Pregnancy
Current Pharmaceutical Biotechnology Is Peri-Operative Isolated Systolic Hypertension (ISH) a Cardiac Risk Factor?
Current Cardiology Reviews Capillary Degeneration and Right Ventricular Remodeling Due to Hypoxic Stress with Sugen5416
Current Vascular Pharmacology Design, Synthesis, and Structure-Activity Relationship Study of Peroxisome Proliferator-Activated Receptor (PPAR) δ-Selective Ligands
Current Medicinal Chemistry New Perspectives in the Treatment of Cushings Syndrome
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Beneficial Effects of Corn Silk on Metabolic Syndrome
Current Pharmaceutical Design The Role of Immunosuppressive Medications in the Pathogenesis of Hypertension and Efficacy and Safety of Antihypertensive Agents in Kidney Transplant Recipients
Current Medicinal Chemistry Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome
Current Vascular Pharmacology Diltiazem Analogues: The Last Ten Years on Structure Activity Relationships
Current Medicinal Chemistry A Review of Hypertension Management in Atrial Fibrillation
Current Hypertension Reviews The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential
Current Medicinal Chemistry Alterations in Plasma Triglyceride Concentrations Following Two Oral Meals with Different Fat Content in Patients with Type 2 Diabetes Mellitus
Current Vascular Pharmacology Novel Strategies in the Treatment of Pulmonary Arterial Hypertension
Current Drug Targets